KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Operating Leases: 2019-2025

Historic Operating Leases for Charles River Laboratories International (CRL) over the last 7 years, with Sep 2025 value amounting to $443.2 million.

  • Charles River Laboratories International's Operating Leases rose 2.39% to $443.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $443.2 million, marking a year-over-year increase of 2.39%. This contributed to the annual value of $483.8 million for FY2024, which is 2.03% up from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Operating Leases is $443.2 million, which was down 2.31% from $453.7 million recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Operating Leases peaked at $483.8 million during Q4 2024, and registered a low of $198.9 million during Q1 2021.
  • Moreover, its 3-year median value for Operating Leases was $432.8 million (2024), whereas its average is $438.1 million.
  • As far as peak fluctuations go, Charles River Laboratories International's Operating Leases soared by 60.83% in 2021, and later decreased by 0.04% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Operating Leases (Quarterly) stood at $286.2 million in 2021, then soared by 52.41% to $436.3 million in 2022, then climbed by 8.68% to $474.1 million in 2023, then increased by 2.03% to $483.8 million in 2024, then rose by 2.39% to $443.2 million in 2025.
  • Its last three reported values are $443.2 million in Q3 2025, $453.7 million for Q2 2025, and $475.1 million during Q1 2025.